Works matching IS 00278874 AND DT 2023 AND VI 115 AND IP 11

Results: 28
    1
    2
    3

    Response to Lehrer and Rheinstein.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1429, doi. 10.1093/jnci/djad168
    By:
    • Lu, Kai;
    • Lin, Jing-Jer
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    EZH2 inhibition: it's all about the context.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1246, doi. 10.1093/jnci/djad141
    By:
    • Rosen, Ezra Y;
    • Shukla, Neerav N;
    • Bender, Julia L Glade
    Publication type:
    Article
    10
    11
    12
    13

    Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1318, doi. 10.1093/jnci/djad116
    By:
    • Barele, Mark van;
    • Akdeniz, Delal;
    • Heemskerk-Gerritsen, Bernadette A M;
    • Genepso;
    • Andrieu, Nadine;
    • Noguès, Catherine;
    • HEBON;
    • Asperen, Christi J van;
    • Wevers, Marijke;
    • Ausems, Margreet G E M;
    • Bock, Geertruida H de;
    • Dommering, Charlotte J;
    • Gómez-García, Encarnacion B;
    • Leeuwen, Flora E van;
    • Mooij, Thea M;
    • EMBRACE;
    • Easton, Douglas F;
    • Antoniou, Antonis C;
    • Evans, D Gareth;
    • Izatt, Louise
    Publication type:
    Article
    14

    Improving combination therapies: targeting A<sub>2B</sub>-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1404, doi. 10.1093/jnci/djad091
    By:
    • Evans, Jason V;
    • Suman, Shankar;
    • Goruganthu, Mounika Uttam L;
    • Tchekneva, Elena E;
    • Guan, Shuxiao;
    • Arasada, Rajeswara Rao;
    • Antonucci, Anneliese;
    • Piao, Longzhu;
    • Ilgisonis, Irina;
    • Bobko, Andrey A;
    • Driesschaert, Benoit;
    • Uzhachenko, Roman V;
    • Hoyd, Rebecca;
    • Samouilov, Alexandre;
    • Amann, Joseph;
    • Wu, Ruohan;
    • Wei, Lai;
    • Pallerla, Aaditya;
    • Ryzhov, Sergey V;
    • Feoktistov, Igor
    Publication type:
    Article
    15

    A framework for assessing interactions for risk stratification models: the example of ovarian cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1420, doi. 10.1093/jnci/djad137
    By:
    • Phung, Minh Tung;
    • Lee, Alice W;
    • McLean, Karen;
    • Anton-Culver, Hoda;
    • Bandera, Elisa V;
    • Carney, Michael E;
    • Chang-Claude, Jenny;
    • Cramer, Daniel W;
    • Doherty, Jennifer Anne;
    • Fortner, Renee T;
    • Goodman, Marc T;
    • Harris, Holly R;
    • Jensen, Allan;
    • Modugno, Francesmary;
    • Moysich, Kirsten B;
    • Pharoah, Paul D P;
    • Qin, Bo;
    • Terry, Kathryn L;
    • Titus, Linda J;
    • Webb, Penelope M
    Publication type:
    Article
    16
    17
    18
    19
    20

    The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1392, doi. 10.1093/jnci/djad126
    By:
    • Nieto, Cera;
    • Miller, Bettina;
    • Alzofon, Nathaniel;
    • Chimed, Tugy;
    • Himes, Jack;
    • Joshi, Molishree;
    • Gomez, Karina;
    • Chowdhury, Farshad N;
    • Le, Phuong N;
    • Weaver, Alice;
    • Somerset, Hilary;
    • Morton, J Jason;
    • Wang, Jing H;
    • Wang, Xiao-Jing;
    • Gao, Dexiang;
    • Hansen, Kirk;
    • Keysar, Stephen B;
    • Jimeno, Antonio
    Publication type:
    Article
    21
    22

    Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1355, doi. 10.1093/jnci/djad085
    By:
    • Chi, Susan N;
    • Yi, Joanna S;
    • Williams, P Mickey;
    • Roy-Chowdhuri, Sinchita;
    • Patton, David R;
    • Coffey, Brent D;
    • Reid, Joel M;
    • Piao, Jin;
    • Saguilig, Lauren;
    • Alonzo, Todd A;
    • Berg, Stacey L;
    • Ramirez, Nilsa C;
    • Jaju, Alok;
    • Mhlanga, Joyce C;
    • Fox, Elizabeth;
    • Hawkins, Douglas S;
    • Mooney, Margaret M;
    • Takebe, Naoko;
    • Tricoli, James V;
    • Janeway, Katherine A
    Publication type:
    Article
    23
    24

    Prediction of breast cancer risk for sisters of women attending screening.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1310, doi. 10.1093/jnci/djad101
    By:
    • Mao, Xinhe;
    • He, Wei;
    • Eriksson, Mikael;
    • Lindström, Linda S;
    • Holowko, Natalie;
    • Bajalica-Lagercrantz, Svetlana;
    • Hammarström, Mattias;
    • Grassmann, Felix;
    • Humphreys, Keith;
    • Easton, Douglas;
    • Hall, Per;
    • Czene, Kamila
    Publication type:
    Article
    25
    26
    27

    Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1302, doi. 10.1093/jnci/djad078
    By:
    • Mamounas, Eleftherios P;
    • Bandos, Hanna;
    • Rastogi, Priya;
    • Lembersky, Barry C;
    • Jeong, Jong-Hyeon;
    • Geyer, Charles E;
    • Fehrenbacher, Louis;
    • Chia, Stephen K;
    • Brufsky, Adam M;
    • Walshe, Janice M;
    • Soori, Gamini S;
    • Dakhil, Shaker R;
    • Wade, James L;
    • McCarron, Edward C;
    • Swain, Sandra M;
    • Wolmark, Norman
    Publication type:
    Article
    28